BackNeuronetics Overview

Neuronetics Current Cash

Track Neuronetics's current cash ($22M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$22.11M
↓ 20.97% YoYΔ $-5.87M vs prior year quarter

Peer trimmed avg / median

Loading

Neuronetics Current Cash History

Loading

Neuronetics vs. peers: Current Cash Comparison

Loading

Neuronetics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Neuronetics (STIM) FAQ

Neuronetics (STIM) currently reports a current cash of $22M as of September 2026. That compares with $28M in the prior-year period — down 21.0% year over year. Use the charts on this page to explore Neuronetics's current cash history and peer comparisons.

Neuronetics's current cash decreased from $28M to $22M — a 21.0% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Neuronetics reported $22M in current cash as of September 2026. That compares with $28M in the prior-year period — down 21.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $22M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Neuronetics, and consider following STIM for alerts when major investors trade the stock.

Neuronetics is classified in the Healthcare sector. On current cash, it currently shows $22M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing STIM with unrelated industries.